Buffer 10X w/BSA - 40MM mgcl(2), product # 1769 (green cap) , buffer 10X w/BSA - 50MM mgcl(2), product # 1768 (orange cap)
Ended Purchase Order Awarded
- Contract number
- N3239825PA301
- Awardee
-
Biofire Defense LLC UEI NHMDGM122546
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $105,228
Award facts
- Opportunity
-
- vitro diagnostic substances, reagents, test kits and sets Special Notice · N3239825Q0154 · Posted Feb 22, 2025
- Contract value 100% obligated
- $105,228.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Millcreek, UT 84107, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of the Navy Naval Supply Systems Command awarded a $105,228 firm fixed-price purchase order to Biofire Defense LLC on May 14, 2025, for the procurement of in-vitro diagnostic buffer solutions and reagent components. The contract calls for 1,000 units of Product Code 1769 (Buffer 10X with Bovine Serum Albumin in 40mm Magnesium Chloride with green cap) and 6,000 units of Product Code 1768 (Buffer 10X with Bovine Serum Albumin in 50mm Magnesium Chloride with orange cap). These specialized diagnostic substances are essential reagent components for Biofire Defense's molecular diagnostic platforms used in biological agent detection and pathogen identification. The contract carries no set-aside designation and utilizes Research, Development, Test & Evaluation funding through the Bureau of Medicine and Surgery, with performance to be completed by May 30, 2025.
The award supports the Naval Medical Research Center's biological defense research and diagnostic capabilities at Fort Detrick, Maryland. Biofire Defense LLC, a Salt Lake City-based manufacturer of advanced molecular diagnostic technologies established as a federal contractor since 2001, was selected as the sole awardee based on the company's unique qualifications and specialized reagent capabilities. This purchase order represents part of the company's broader federal contracting portfolio serving the Department of Defense and other government agencies for biodefense and public health preparedness missions, leveraging the company's core diagnostic product expertise and established supply chain relationships.
Quick answers
Who was awarded contract N3239825PA301?
N3239825PA301 was awarded to Biofire Defense LLC by Bureau of Medicine and Surgery (Department of the Navy) on May 14, 2025.
How much is contract N3239825PA301 worth?
The government has obligated $105,228 on N3239825PA301.
Was contract N3239825PA301 competed?
The extent of competition for N3239825PA301 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award